Posted by Michael Wonder on 23 Apr 2018
Company urged to lower cost of life-changing drug for cystic fibrosis
21 April 2018 - Health ministers have urged a pharmaceutical company to drop the price of a life-changing cystic fibrosis (CF) drug for NHS patients.
Vertex Pharmaceuticals' Orkambi costs £100,000 a year per patient, and has been deemed too expensive for the NHS.
The company rejected an NHS England counter offer, saying it was not enough to fund research into future medicines.
